Drug Shortage Report for PMS-IMATINIB

Last updated on 2021-11-15 History
Report ID 149326
Drug Identification Number 02431114
Brand name PMS-IMATINIB
Common or Proper name IMATINIB
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) IMATINIB
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 12x10
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-11-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-11-15 French Compare
v1 2021-11-15 English Compare

Showing 1 to 2 of 2